Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

United Medical

This article was originally published in The Gray Sheet

Executive Summary

Plans to go private via a $9.50 per share cash offer for 48% of the 2.6 mil. shares of United Medical stock outstanding. The remaining 52% of United's stock is held by Chairman John Aglialoro and President Joan Carter, who will retain ownership of the company. There "is no financing contingency for the transaction," which is expected to close 30 days after receipt of approval by the company's public shareholders and the consent of existing lenders. Among reasons cited by the company for going private is that United Medical stock has typically traded below book value, which currently is $10.27 per share. The stock closed at $6.375 on Dec. 31 -- the last trading day before the company's Jan. 4 announcement -- and at $9.25 on Jan. 4....

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000095

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel